AngellaBarrMD

Summary

• Chemical Dependency Treatment Associates Inc. provides comprehensive and outcome-based services to chemically dependent people and their families in a safe, sustainable and diverse environment. All services are offered on an outpatient basis. CDTA treats patients at all stages of the substance abuse cycle:
  
  • Active users who have never sought formal treatment.
  • Prescription opioid users whose use of opioids is out of control.
  • Patients in the early stages of recovery who are struggling with physical withdrawal and cravings.
  • Patients active in recovery who experience a short or long-term relapse.
  • Recovering patients who are dealing with family issues related to substance abuse.
  
  Our philosophy is to “meet patients where they are,” with the end-goal being a healthier, more productive lifestyle. CDTA assists with all chemical substances of abuse, including alcohol, tobacco, marijuana, heroin, prescription opioids, methamphetamines, club drugs, and benzodiazepines.
  
  CDTA practices listening, understand and compassion to guide our patients toward a treatment plan that is realistic and attainable. We take the time and care to assess, plan, measure, reassess and adapt. The working relationships with our patients are dynamic, as is the recovery process.
  
  Dr. Angella Barr joined CDTA Inc. in February, 2015 and assumed responsibility for its business administration. Dr. Barr is a fellow-trained and board certified addiction medicine specialist, with a unique skill for buprenorphine (Suboxone) treatment for addiction and pain. Her other specialties include general medication management and treating chemical dependencies during pregnancy.
  
  Dr. Barr received her B.S. from the University of Nevada, Reno and her M.D. from Columbia University of Physicians and Surgeons, New York, N.Y. She also received specialized training in psychotherapy.